Re:GEN Open
@regenopen
A dynamic #openaccess journal publishing advances across all aspects of basic and translational #biomedical research, from @LiebertPub & @GENbio
ID: 1357447499347353604
http://www.regenopen.com/ 04-02-2021 21:54:44
57 Tweet
50 Takipçi
90 Takip Edilen
"Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins" - Read more from this Cell article here: cell.com/cell/fulltext/… Broad Institute David R. Liu
Submit to Re:GEN Open for #OpenAccess Publication This exciting new journal is dedicated to publishing advances across all aspects of basic & translational #biomedical research in the form of original articles, reviews, commentaries, & briefs. Learn more: ow.ly/ZsnF50HFHPP
Potential of Favipiravir and Minocycline Combination Therapy for COVID-19: ow.ly/ZIlR50HPIjA #Favipiravir #Minocycline #CombinationTherapy #InflammatoryCytokine #AntiviralAgent #AntibacterialAgent #COVID19 #SARSCoV2 #Pandemic Re:GEN Open
Potential “Holy Grail” for Generating Biomedically Relevant Cells through #CellFateEngineering Review in Re:GEN Open demonstrates novel ways in manipulating cellular identities for #regenerativemedicine applications using #CRISPRCas9-based #geneediting: ow.ly/H64250Ie5CU
Submit #Abstract TERMIS SYIS EU TERMIS-AM SYIS TERMIS-AM TERMIS-EU for #symposium #biofabrication TERMIS-AP 2022. Splendid program and wonderful location! #science #research #conference
Essential perspective by law professor Jacob Sherkow Jacob S. Sherkow (@[email protected]) of the recent PTAB ruling in the long-running #CRISPR patent dispute Broad Institute UC Berkeley Editas Medicine Intellia Therapeutics CRISPR Therapeutics ERS Genomics